• Profile
Close

Abnormalities of laboratory coagulation tests vs clinically evident coagulopathic bleeding: Results from the Prehospital Resuscitation on Helicopter Study (PROHS)

Surgery Jan 05, 2018

Chang R, et al. - A prospective observational study of adult trauma patients transported by helicopter was planned to describe clinically-evident coagulopathy (CC) among trauma patients. Compared to laboratory-based evidence of coagulopathy (LC), CC was rare. Researchers observed poor outcomes and impairment of both clotting factor and platelet-mediated coagulation components in association with CC.

Methods

  • Adult trauma patients transported by helicopter from the scene to nine Level 1 trauma centers in 2015 were prospectively observed.
  • Division of patients meeting predefined highest-risk criteria into CC+ (predefined as surgeon-confirmed bleeding from uninjured sites or injured sites not controllable by sutures) or CC- was performed.
  • A mixed-effects, Poisson regression with robust error variance was used to test the hypothesis that abnormalities on rapid thrombelastography (r-TEG) and international normalized ratio (INR) were independently associated with CC+.

Results

  • Researchers identified 1,019 highest-risk patients.
  • Among these, CC+ (n=41, 4%) patients were more severely injured (median ISS 32 vs 17), had evidence of LC on r-TEG and INR, received more transfused blood products at 4 hours (37 vs 0 units), and had greater 30-day mortality (59% vs 12%) than CC- (n=978, 96%).
  • Observations revealed the overall LC incidence of 39%.
  • In those with and without LC, 30-day mortality was 22% vs 9%.
  • In two separate models, r-TEG K-time >2.5 min (RR 1.3, 95% CI 1.1-1.7), r-TEG mA <55 mm (RR 2.5, 95% CI 2.0-3.2), platelet count <150 x 109/L (RR 1.2, 95% CI 1.1-1.3), and INR >1.5 (RR 5.4, 95% CI 1.8-16.3) seemed to have independent association with CC+.
  • As too few patients underwent both r-TEG and INR, a combined regression model was not generated.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay